• Mithra and Gedeon Richter sign supply agreement for production of API for Estelle® and Donesta®

    Wednesday August 9th 2023

  • Mithra receives EUR 1.25 million milestone payment from Fuji Pharma under Estelle® licensing agreement

    Thursday August 3rd 2023

  • Deep learning helps to find new targets in soy for crop improvement

    Thursday August 3rd 2023

  • Mithra and Searchlight Pharma announce Donesta® licensing agreement for Canada

    Monday July 31st 2023

  • ‘Human inks’ to 3D printing human tissues: HU3DINKS project brings together expert companies for the development of human tissue-based inks

    Monday July 24th 2023

  • argenx raises $1.1 billion in gross proceeds in a global offering

    Wednesday July 19th 2023

  • Biocartis appoints George Cardoza as new CFO and Head of Service Delivery

    Tuesday July 18th 2023

  • argenx reports positive topline data from ADHERE study of VYVGART Hytrulo in patients with chronic inflammatory demyelinating polyneuropathy

    Monday July 17th 2023

  • Your news here?

  • VUB neurologist argues for affordability of new Alzheimer’s drug

    Friday July 14th 2023

  • Aphea.Bio secures € 70 million Series C Funding, accelerating the company’s commercialisation efforts

    Tuesday July 11th 2023

  • Sequana Medical announces first patient enrolled in MOJAVE, a US randomized controlled Phase 1/2a study of DSR® 2.0 for treatment of congestive heart failure

    Monday July 10th 2023

Strategic Partners